"We provide the state-of-the-art care to let you get back to the things you enjoy. GastroIntestinal Diseases, Inc., through its providers, delivers professional care for various digestive diseases. We offer a wide range of diagnostic and therapeutic options. We perform upper and lower endoscopies as well as other diagnostic studies such as laboratory tests, ultrasound and CT scans in order to properly and promptly diagnosis digestive disorders. We also provide screenings, such as colonoscopies, for various gastrointestinal diseases for the diagnosis and prevention of colon cancer. We have been providing care in the greater Columbus area for more than 20 years."

During the past decade, Gastrointestinal Diseases Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastrointestinal Diseases Research" #1 sponsor was "Celgene" with 3 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Guardant Health, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastrointestinal Diseases Research" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal Diseases Research" are "Crohn Disease" (4 trials), "Colorectal Cancer" (1 trials), "Nonalcoholic Steatohepatitis" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Gastrointestinal Diseases Research" in a lesser frequency.

Most popular intervention types in "Gastrointestinal Diseases Research" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "CILO" (1 trials), "Etrolizumab" (1 trials) and "FIR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal Diseases Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Gastrointestinal Diseases Research". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gastrointestinal Diseases Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal Diseases Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".